Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas

Journal of Cutaneous Pathology

Volumn 31, Issue 5, 2004, Pages 362-367

  Franke, Folker E ^a   Steger, Klaus ^a   Marks, Alexander ^b   Kutzner, Heinz ^c   Mentzel, Thomas ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF TORONTO   (Canada)

^c Dermatohistology Laboratory   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CD31 ANTIGEN; CD34 ANTIGEN; CELL MARKER; HEMOSIDERIN; PARAFFIN;

ARTICLE; CELL LABELING; ENDOTHELIUM CELL; ERYTHROCYTE; HEMANGIOMA; HISTOLOGY; HOBNAIL HEMANGIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOMA; PERICYTE; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

ACTINS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; ANTIGENS, CD34; BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; HEMANGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOMA; MUSCLE, SMOOTH; SKIN NEOPLASMS;

EID: 1942532323     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00192.x     Document Type: Article

References (22)

1. Santa Cruz DJ, Aronberg J. Targetoid hemosiderotic hemangioma. J Am Acad Dermatol 1988; 19: 550.
2. Guillou L, Calonje E, Speight P, Rosai J, Fletcher CD. Hobnail hemangioma: a pseudomalignant vascular lesion with a reappraisal of targetoid hemosiderotic hemangioma. Am J Surg Pathol 1999; 23: 97.
3. Calonje E, Fletcher CD, Wilson-Jones E, Rosai J. Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases. Am J Surg Pathol 1994; 18: 115.
4. Fanburg-Smith JC, Michal M, Partanen TA, Alitalo K, Miettinen M. Papillary intralymphatic angioendothelioma (PILA): a report of twelve cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels. Am J Surg Pathol 1999; 23: 1004.
5. Mentzel T, Partanen TA, Kutzner H. Hobnail hemangioma ('targetoid hemosiderotic hemangioma'): clinicopathologic and immunohistochemical analysis of 62 cases. J Cutan Pathol 1999; 26: 279.
6. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92: 3566.
7. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999; 154: 385.
8. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789.
9. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769.
10. Wilting J, Papoutsi M, Christ B, et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002; 16: 1271.
11. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001; 158: 867.
12. Lymboussaki A, Partanen TA, Olofsson B, et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 1998; 153: 395.
13. Weninger W, Partanen TA, Breiteneder-Geleff S, et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 1999; 79: 243.
14. Folpe AL, Veikkola T, Valtola R, Weiss SW. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 2000; 13: 180.
15. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999; 86: 2406.
16. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 2002; 15: 434.
17. Kahn HJ, Marks A. A new monoclonal antibody, D2, for detection of lymphatic invasion in primary tumors. Lab Invest 2002; 82: 1255.
18. Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 1999; 80: 569.
19. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 2002; 16: 773.
20. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H-and Y-antigens - evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994; 7: 82.
21. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001; 276: 19420.
22. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs. blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 1998; 46: 165.